Litigation industry forces continue to evolve. This week, 41 Attorneys General signed a letter supporting legislation to overturn the U.S. Supreme Court’s decision prohibiting failure to warn product liability lawsuits against generic drug manufacturers. The group includes both Republicans and Democrats. Thus, it appears both sides recognize that it is short-sighted and not desirable to let generic manufacturers escape the risks and potential liabilities that face brand name manufacturers.
Comments